JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
Scope & Guideline
Elevating discourse in microbiology and infection studies.
Introduction
Aims and Scopes
- Clinical Microbiology and Infectious Diseases:
The journal emphasizes research on various infectious diseases, including bacterial, viral, and fungal pathogens. Studies often focus on clinical characteristics, treatment outcomes, and antimicrobial resistance patterns. - Immunology and Host Response:
Research that explores the immune response to infections, vaccine efficacy, and the interplay between pathogens and the host's immune system is a central theme. This includes studies on T-cell responses, antibody production, and immunological markers. - Antimicrobial Resistance:
A significant focus is placed on understanding the mechanisms and epidemiology of antimicrobial resistance, particularly among gram-negative bacteria and other clinically relevant pathogens. This includes studies on resistance genes, phenotypic resistance, and the impact of antimicrobial stewardship. - Epidemiology and Public Health:
The journal publishes research that investigates the epidemiological trends of infectious diseases, including outbreaks, risk factors, and population-based studies that inform public health strategies. - Innovative Diagnostic Methods:
Research on novel diagnostic techniques, including molecular methods like PCR and metagenomics, is also highlighted, reflecting the journal's commitment to improving diagnostic accuracy and speed for infectious diseases.
Trending and Emerging
- COVID-19 Research:
Research related to COVID-19, including its clinical manifestations, treatment protocols, and long-term sequelae, has surged. This reflects the pandemic's significant impact on global health and the urgent need for understanding its implications. - Antimicrobial Stewardship and Resistance:
There is an increasing focus on studies addressing antimicrobial stewardship programs, strategies to combat antimicrobial resistance, and the development of novel antimicrobial agents. - Long COVID and Post-Infectious Syndromes:
Emerging studies on Long COVID and other post-infectious syndromes are gaining attention, highlighting the need for ongoing research into the long-term effects of viral infections. - Vaccine Development and Response:
Research on vaccine efficacy, safety, and the immune response to various vaccines, especially in immunocompromised populations, is trending, reflecting the global emphasis on vaccination as a public health strategy. - Microbiome Studies:
Investigation into the role of the microbiome in health and disease, particularly its interaction with infectious agents and impact on treatment outcomes, is gaining traction.
Declining or Waning
- Non-Infectious Disease-Related Immunology:
Research focusing solely on immunology without a direct connection to infectious diseases appears to be waning. The journal's current trend favors studies that link immunological mechanisms to infectious disease outcomes. - Traditional Laboratory Techniques:
There is a noticeable decline in studies relying solely on traditional microbiological techniques, such as culture-based methods, as newer, more rapid diagnostic methods gain traction. - Epidemiological Studies of Established Pathogens:
Epidemiological research on well-established pathogens, which previously received significant attention, is becoming less frequent as emerging pathogens and their associated diseases take precedence. - Localized Studies:
Studies focused on localized outbreaks or regional infections without broader implications or connections to global health concerns are less common, possibly due to a shift towards research with wider applicability.
Similar Journals
Journal of Pathogens
Bridging Knowledge Gaps in Pathogenesis and Public HealthJournal of Pathogens is a premier peer-reviewed journal published by HINDAWI LTD, focusing on the critical field of microbiology, infectious diseases, and the mechanisms of pathogen interactions with hosts. Since its inception in 2011 as an Open Access journal, it has aimed to provide a platform for high-quality research articles, reviews, and case studies that enhance our understanding of pathogenesis and advance the science of disease control. With its commitment to making research freely accessible, the journal attracts a global audience of researchers, professionals, and graduate students keen on exploring innovative findings and applications in the study of pathogens. While the journal does not currently have an established H-index or category quartiles, its relevance and importance in the field continue to grow as it seeks to bridge knowledge gaps and facilitate impactful discussions in infectious disease research. Located at Adam House, 3rd Floor, 1 Fitzroy Square, London W1T 5HF, England, the Journal of Pathogens invites submissions that contribute to the ever-evolving landscape of pathogen research and public health.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
Driving Excellence in Infectious Disease SolutionsDIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, published by Elsevier Science Inc, is a leading journal in the fields of Infectious Diseases, Microbiology, and Medicine. Since its inception in 1983, this esteemed journal has consistently provided a platform for original research and comprehensive reviews that advance the understanding of diagnostic microbiology and its implications for infectious diseases. With an impressive impact factor placing it in the Q2 category in multiple relevant fields as of 2023, it stands out with Scopus rankings reinforcing its significance in academia, ranking #136 out of 344 in Infectious Diseases and #64 out of 140 in Medical Microbiology. This journal is essential for researchers, healthcare professionals, and students who seek to stay abreast of the latest developments and trends in infectious diagnostics. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE is committed to fostering excellence in research quality and academic rigor, ensuring accessibility to vital knowledge for addressing some of the most pressing health challenges of our time.
Reviews and Research in Medical Microbiology
Illuminating the Evolving Landscape of Microbial ResistanceReviews and Research in Medical Microbiology is a premier academic journal published by LIPPINCOTT WILLIAMS & WILKINS, focusing on groundbreaking research and comprehensive reviews that advance the understanding of medical microbiology. With an ISSN of 2770-3150 and an E-ISSN of 2770-3169, this journal serves as an essential resource for researchers, healthcare professionals, and students dedicated to the study of pathogens, infectious diseases, and microbial mechanisms affecting health. While the journal currently does not offer open access, its rigorous peer-review process ensures that only high-quality, impactful research is disseminated to the scientific community. The journal aims to bridge gaps in knowledge by presenting cutting-edge studies that explore novel therapeutic strategies, diagnostic methods, and the evolving landscape of microbial resistance. Nestled in the heart of Philadelphia, this journal proudly contributes to the advancement of medical microbiology and is an indispensable platform for the publication of critical findings that shape clinical practices and research trajectories in the field.
Gut Pathogens
Unlocking Insights for Better Gut HealthGut Pathogens, published by BMC in the United Kingdom, is a premier open-access journal focusing on the intersection of gut health and infectious diseases. With its impact firmly established since its inception in 2009, the journal has earned impressive rankings, including Q1 in renowned categories such as Gastroenterology, Infectious Diseases, Microbiology, and Parasitology, while maintaining a strong presence in Virology. The journal serves as a vital resource for researchers, professionals, and students interested in the intricate relationships between gut microbiota and pathogenic organisms, offering insights that drive advancements in treatment and prevention strategies. By providing unrestricted access to high-quality research, Gut Pathogens fosters a collaborative environment, encouraging the dissemination of knowledge and innovation within the field. The journal publishes original research, reviews, and case studies, all designed to address contemporary challenges in gut health, ultimately aiming to improve patient outcomes and public health worldwide.
MICROBES AND INFECTION
Transforming Knowledge into Clinical PracticeMICROBES AND INFECTION is a premier academic journal published by Elsevier, dedicated to the dynamic fields of immunology, infectious diseases, and microbiology. With a notable impact factor reflective of its high-quality research contributions, the journal is categorized in the Q2 quartile across these fields as of 2023. Based in France and operating since 1999, MICROBES AND INFECTION offers a platform for researchers, professionals, and students to disseminate and access cutting-edge findings that drive innovation and knowledge in microbial and infectious disease research. The journal is ranked impressively within the Scopus database, securing ranks such as #16 in Microbiology and #33 in Infectious Diseases, underscoring its high relevance in the scientific community. Subscribers to the journal can expect an array of articles, reviews, and original research, all designed to advance understanding and improve clinical practices in the fight against infectious agents. With its ongoing commitment to open access options, MICROBES AND INFECTION continues to foster global collaboration and information sharing in the pursuit of addressing pressing microbiological challenges.
Mediterranean Journal of Infection Microbes and Antimicrobials
Connecting researchers to combat microbial threats.Mediterranean Journal of Infection Microbes and Antimicrobials is a distinguished open-access journal published by GALENOS PUBL HOUSE, dedicated to advancing the understanding of infectious diseases and microbiology. Since its inception in 2011, this journal has been a vital resource for researchers, professionals, and students interested in the intricate world of microbes and their impacts on human health. With its ISSN 2147-673X, the journal has progressively gained visibility, although it currently holds a Q4 ranking in multiple categories including Immunology and Microbiology, and Infectious Diseases for the year 2023. The journal operates from its headquarters in Istanbul, Turkey, and features a rich array of articles that contribute to the field’s body of knowledge. As a platform enhancing the accessibility of research, it invites submissions from global contributors to foster collaboration and innovation in tackling microbial challenges.
EPIDEMIOLOGIE MIKROBIOLOGIE IMUNOLOGIE
Advancing Knowledge in Health SciencesEPIDEMIOLOGIE MIKROBIOLOGIE IMUNOLOGIE is a prominent scholarly journal published by CESKA LEKARSKA SPOLECNOST J EV PURKYNE in the Czech Republic. With an ISSN of 1210-7913, this journal has been at the forefront of research since its inception in 1994, showcasing a rich repository of studies bridging the domains of epidemiology, microbiology, immunology, and infectious diseases, and reflecting advancements over three decades. Although it currently falls within the Q4 category in multiple fields including Epidemiology and Microbiology, the journal serves an essential role in disseminating knowledge and fostering discussions around public health challenges. The contributions made through its pages are vital for researchers, healthcare professionals, and students aiming to enhance their understanding of complex biomedical issues. While it does not offer open access, the journal remains a critical resource in its niches, inviting readers to engage with the latest findings and methodologies reshaping the landscape of health science.
MIKROBIYOLOJI BULTENI
Exploring Innovations in Infectious Disease ResearchMIKROBIYOLOJI BULTENI, with ISSN 0374-9096, is a prestigious academic journal published by the ANKARA MICROBIOLOGY SOC, located in Ankara, Turkey. Established in 1973, this journal has been a vital conduit for disseminating research in the fields of Immunology, Microbiology, and Infectious Diseases, garnering a reputation as a significant contributor to the scientific community. The journal is currently ranked in the Q3 category within Immunology and Microbiology (miscellaneous), and Infectious Diseases, indicating its impactful presence amidst contemporary research. With access options that may be restricted, MIKROBIYOLOJI BULTENI actively welcomes submissions that advance the understanding of critical microbiological principles and practices, thereby supporting both national and international research efforts. Researchers, professionals, and students are encouraged to explore the latest findings shared in this journal, as it continually shapes the landscape of microbiology and infectious disease studies through its comprehensive and rigorous peer-reviewed publications.
CLINICAL MICROBIOLOGY REVIEWS
Advancing the frontiers of microbiology knowledge.CLINICAL MICROBIOLOGY REVIEWS, published by the American Society for Microbiology, is a leading journal in the fields of epidemiology, immunology, and microbiology, notably recognized for its Q1 status in multiple categories such as Infectious Diseases and Public Health. With an ISSN of 0893-8512 and E-ISSN of 1098-6618, this esteemed journal offers comprehensive reviews and analyses that contribute to the advancement of clinical microbiology practices worldwide. Since its inception in 1988, it has established itself as a pivotal resource for researchers and healthcare professionals, delivering high-quality, peer-reviewed articles that are instrumental in understanding microbial diseases. The journal is highly regarded in the academic community, boasting impressive Scopus rankings, including Rank #1 in Medical Microbiology and a commendable 99th percentile in Public Health. Although not available as an open-access publication, CLINICAL MICROBIOLOGY REVIEWS remains an essential tool for those seeking to enhance their knowledge and practice in microbiology, making significant impacts on clinical outcomes and public health initiatives.
JOURNAL OF INFECTIOUS DISEASES
Shaping the Future of Infectious Disease ScienceThe JOURNAL OF INFECTIOUS DISEASES, published by OXFORD UNIV PRESS INC, is a leading peer-reviewed journal dedicated to advancing the understanding of infectious diseases through high-quality research. With an impressive impact factor reflecting its prominence in the field—ranking in the Q1 category for both Immunology and Allergy and Infectious Diseases—this journal serves as a pivotal platform for researchers, healthcare professionals, and students alike. Its extensive history, spanning over a century since its inception in 1904, highlights its established authority and commitment to the field. Based in the United Kingdom, the journal covers essential topics from clinical management to epidemiological trends, providing vital insights that inform practice and policy. Although the journal is not open access, it remains accessible to a wide audience, ensuring that critical research continues to drive innovation and best practices in infectious disease management.